Pretreatment radiomic biomarker for immunotherapy responder prediction in stage IB–IV NSCLC (LCDigital-IO Study): a multicenter retrospective study

Background The predictive efficacy of current biomarker of immune checkpoint inhibitors (ICIs) is not sufficient. This study investigated the causality between radiomic biomarkers and immunotherapy response status in patients with stage IB–IV non-small cell lung cancer (NSCLC), including its biologi...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Bin Xu, Lan Liu, Shaowei Wu, Guangyi Wang, Guibin Qiao, Weijie Zhan, Daipeng Xie, Lintong Yao, Henian Yao, Guoqing Liao, Luyu Huang, Yubo Zhou, Peimeng You, Zekai Huang, Qiaxuan Li, Siyun Wang, Dong-Kun Zhang, Lawrence Wing-Chi Chan, Michael Lanuti, Haiyu Zhou
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	BMJ Publishing Group 2023-10-01
سلاسل:	Journal for ImmunoTherapy of Cancer
الوصول للمادة أونلاين:	https://jitc.bmj.com/content/11/10/e007369.full
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!